These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32163149)

  • 1. Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrospective Clinical Data Analysis.
    Sturgeon JA; Sullivan MD; Parker-Shames S; Tauben D; Coelho P
    Pain Med; 2020 Dec; 21(12):3635-3644. PubMed ID: 32163149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series.
    Murray JP; Pucci G; Weyer G; Ari M; Dickson S; Kerins A
    Addict Sci Clin Pract; 2023 Jun; 18(1):38. PubMed ID: 37264449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative Analysis of Patient Perspectives of Buprenorphine After Transitioning From Long-Term, Full-Agonist Opioid Therapy Among Veterans With Chronic Pain.
    Edmond SN; Wesolowicz DM; Snow JL; Currie S; Jankelovits A; Chhabra MS; Becker WC
    J Pain; 2024 Jan; 25(1):132-141. PubMed ID: 37549775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
    Patel KV; Sahni S; Taylor LF
    J Osteopath Med; 2023 Jan; 123(1):1-5. PubMed ID: 36282967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.
    Worley MJ; Heinzerling KG; Shoptaw S; Ling W
    Addiction; 2017 Jul; 112(7):1202-1209. PubMed ID: 28164407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE; Tompkins DA; Bigelow GE; Strain EC
    JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid tapering in patients with prescription opioid use disorder: A retrospective study.
    Zhou K; Jia P; Bhargava S; Zhang Y; Reza T; Peng YB; Wang GG
    Scand J Pain; 2017 Oct; 17():167-173. PubMed ID: 28988103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists.
    Thakrar AP; Jablonski L; Ratner J; Rastegar DA
    J Addict Med; 2022 Jan-Feb 01; 16(1):122-124. PubMed ID: 33758112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study.
    Baumgartner K; Salmo E; Liss D; Devgun J; Mullins M; Galati B; Kelly J; Schwarz E
    Clin Toxicol (Phila); 2022 Jun; 60(6):688-693. PubMed ID: 35048759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder.
    Schroeder JR; Phillips KA; Epstein DH; Jobes ML; Furnari MA; Kennedy AP; Heilig M; Preston KL
    Psychopharmacology (Berl); 2018 Oct; 235(10):2957-2966. PubMed ID: 30079432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program.
    Weinstein ZM; Gryczynski G; Cheng DM; Quinn E; Hui D; Kim HW; Labelle C; Samet JH
    Drug Alcohol Depend; 2018 Aug; 189():166-171. PubMed ID: 29958128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine Microdosing Cross Tapers: A Time for Change.
    Raheemullah A; Benhamou OM; Kuo J; Lembke A
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder.
    Becker WC; Ganoczy D; Fiellin DA; Bohnert AS
    J Subst Abuse Treat; 2015 Jan; 48(1):128-31. PubMed ID: 25312475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The problem of pain: Additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder.
    Montalvo C; Genovese N; Renner J
    Subst Abus; 2019; 40(2):136-139. PubMed ID: 30835647
    [No Abstract]   [Full Text] [Related]  

  • 16. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
    Chou R; Ballantyne J; Lembke A
    Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy.
    Mehta D; Thomas V; Johnson J; Scott B; Cortina S; Berger L
    Pain Physician; 2020 Mar; 23(2):E163-E174. PubMed ID: 32214293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review.
    Powell VD; Rosenberg JM; Yaganti A; Garpestad C; Lagisetty P; Shannon C; Silveira MJ
    JAMA Netw Open; 2021 Sep; 4(9):e2124152. PubMed ID: 34495339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically.
    Suzuki J; Matthews ML; Brick D; Nguyen MT; Wasan AD; Jamison RN; Ellner AL; Tishler LW; Weiss RD
    J Opioid Manag; 2014; 10(3):159-68. PubMed ID: 24944066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.